Loading company…
Yantai Midu develops molecular imaging solutions and services for drug research.
Founded in 2022 and based in Yantai, China, Yantai Midu develops molecular imaging medicine and provides drug research solutions. Its services use radiolabeling and in vivo molecular imaging for drug screening, biodistribution, and pharmacokinetic research, as well as outsourced technical support for drug development. In March 2024, it raised a strategic investment of CNY 380 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in